US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 701.850
- -6.400-0.90%
Close Dec 20 16:00 ET
- 706.330
- +4.480+0.64%
Post 20:01 ET
77.13BMarket Cap17.36P/E (TTM)
717.610High700.830Low1.89MVolume710.200Open708.250Pre Close1.33BTurnover1.79%Turnover Ratio20.19P/E (Static)109.89MShares1211.20052wk High2.63P/B73.98BFloat Cap693.00052wk Low--Dividend TTM105.40MShs Float1211.200Historical High--Div YieldTTM2.37%Amplitude4.610Historical Low704.467Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.88%1.29B | -65.38%354M | 10.60%1.51B | -8.39%4.59B | -36.64%1.09B | 77.18%1.11B | 81.15%1.02B | -34.93%1.37B | -29.18%5.01B | -27.51%1.72B |
| Net income from continuing operations | 33.02%1.34B | 47.90%1.43B | -11.71%722M | -8.87%3.95B | -3.13%1.16B | -23.40%1.01B | 13.65%968.4M | -15.99%817.8M | -46.28%4.34B | -46.29%1.2B |
| Operating gains losses | -206.06%-134.7M | -1,370.55%-392.6M | 17.71%196.1M | 623.91%266.4M | 27.92%-58.1M | 150.10%127M | -81.43%30.9M | -18.53%166.6M | 109.51%36.8M | -158.58%-80.6M |
| Depreciation and amortization | 15.46%121.7M | 17.07%120.7M | 14.67%114.1M | 23.32%421M | 12.89%113M | 13.82%105.4M | 38.58%103.1M | 33.92%99.5M | 19.29%341.4M | 34.36%100.1M |
| Deferred tax | -34.13%-168.6M | 43.57%-118.1M | 12.06%-190.4M | -12.25%-837.8M | -2.36%-286.3M | -46.67%-125.7M | -34.17%-209.3M | 3.78%-216.5M | -407.41%-746.4M | -35.84%-279.7M |
| Other non cash items | -145.76%-29M | -134.88%-3M | -99.51%100K | -100.02%-100K | -110.36%-17.5M | -119.44%-11.8M | -96.55%8.6M | -75.56%20.6M | -1.00%563M | -44.46%169M |
| Change In working capital | 66.77%-63.9M | -1,017.47%-908.5M | 82.86%440.5M | 61.32%-94.1M | -116.07%-61.4M | 71.18%-192.3M | 89.59%-81.3M | -70.74%240.9M | 87.30%-243.3M | 207.48%382M |
| -Change in receivables | 16.09%-388.9M | -18,200.00%-494.1M | 112.66%446.8M | -147.87%-338.8M | -137.66%-82.7M | -19.80%-463.5M | 99.16%-2.7M | -82.46%210.1M | 136.72%707.8M | 137.57%219.6M |
| -Change in inventory | -112.95%-164.4M | -81.08%-181.8M | -232.91%-155.8M | 60.99%-271.7M | 67.22%-47.3M | 65.46%-77.2M | 58.18%-100.4M | 47.18%-46.8M | -40.91%-696.5M | 11.85%-144.3M |
| -Change in prepaid assets | 191.47%252M | -15,379.41%-526.3M | -1,316.36%-77.9M | 19.18%-120.1M | 778.61%164.3M | -327.31%-275.5M | 98.60%-3.4M | 87.72%-5.5M | 38.26%-148.6M | -75.43%18.7M |
| -Change in payables and accrued expense | -66.40%194.4M | 415.37%204.6M | -7.14%110.5M | 532.51%598.6M | -139.90%-138.7M | 460.95%578.6M | 152.72%39.7M | 147.52%119M | -115.98%-138.4M | -4.95%347.6M |
| -Change in other working capital | -5.08%43M | 714.48%89.1M | 425.63%116.9M | 16.98%37.9M | 172.15%43M | 355.93%45.3M | -114.47%-14.5M | -477.89%-35.9M | 126.96%32.4M | -21.63%-59.6M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.88%1.29B | -65.38%354M | 10.60%1.51B | -8.39%4.59B | -36.64%1.09B | 77.18%1.11B | 81.15%1.02B | -34.93%1.37B | -29.18%5.01B | -27.51%1.72B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -15.74%-574.4M | 76.66%-557.2M | -615.78%-1.69B | 15.84%-3.19B | 96.44%-66.2M | -358.09%-496.3M | -476.69%-2.39B | 86.18%-235.7M | 29.72%-3.78B | 7.70%-1.86B |
| Capital expenditure reported | -37.44%-241.9M | -59.73%-180.5M | 24.86%-133.9M | -21.78%-718.6M | -65.18%-251.4M | -23.51%-176M | 26.43%-113M | -25.67%-178.2M | -6.92%-590.1M | 1.74%-152.2M |
| Net PPE purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net intangibles purchase and sale | --0 | -45.45%-30.4M | 72.35%-27.9M | 79.76%-207.8M | 37.90%-62.1M | 97.42%-23.9M | ---20.9M | ---100.9M | ---1.03B | ---100M |
| Net business purchase and sale | --0 | ---- | ---- | 76.16%-54.9M | ---3.8M | ---51.1M | ---- | ---- | ---230.3M | --0 |
| Net investment purchase and sale | -35.55%-332.5M | 83.96%-361.4M | -3,614.52%-1.53B | -13.75%-2.2B | 115.64%251.1M | -119.44%-245.3M | -7,410.00%-2.25B | 102.78%43.4M | 59.91%-1.94B | 13.58%-1.61B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -15.74%-574.4M | 76.66%-557.2M | -615.78%-1.69B | 15.84%-3.19B | 96.44%-66.2M | -358.09%-496.3M | -476.69%-2.39B | 86.18%-235.7M | 29.72%-3.78B | 7.70%-1.86B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -55.66%-634M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M | -598.45%-322.5M | -0.32%-1.01B | 72.69%-247.6M |
| Net common stock issuance | -47.46%-600.6M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M | -598.45%-322.5M | -0.32%-1.01B | 72.69%-247.6M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -55.66%-634M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M | -598.45%-322.5M | -0.32%-1.01B | 72.69%-247.6M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.10%1.93B | -33.57%2.61B | -12.23%2.74B | 7.64%3.12B | -38.36%2.16B | -42.80%1.95B | 16.96%3.93B | 7.64%3.12B | 31.30%2.9B | 1.74%3.5B |
| Current changes in cash | -60.70%82.8M | 65.57%-681.3M | -115.75%-127.5M | -272.25%-381.2M | 249.82%577.4M | 119.02%210.7M | -4,105.47%-1.98B | 75.54%809.4M | -67.96%221.3M | 29.52%-385.4M |
| Effect of exchange rate changes | 500.00%800K | 25.00%-300K | ---500K | ---400K | --200K | ---200K | ---400K | --0 | --0 | --0 |
| End cash Position | -6.87%2.01B | -1.10%1.93B | -33.57%2.61B | -12.23%2.74B | -12.23%2.74B | -38.36%2.16B | -42.80%1.95B | 16.96%3.93B | 7.64%3.12B | 7.64%3.12B |
| Free cash flow | 14.75%1.05B | -83.89%143.1M | 24.09%1.35B | 7.93%3.67B | -47.11%776.2M | 307.63%914.4M | 116.29%888.5M | -44.46%1.09B | -47.96%3.4B | -33.82%1.47B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
